September 7, 2021

Treatment without borders: the EU case for equitable patient access to advanced therapies

The EU Pharmaceutical Strategy is looking to improve patients’ access to therapies for challenging and rare conditions. The EU legislation on cross-border healthcare is an important […]
August 2, 2021

EuropaBio response to the European Commission Public Consultation on the Regulations for Orphan Medicinal Products and Paediatrics

EuropaBio has responded to the European Commission’s public consultation on the Orphan Medicinal Products (OMPs) and Paediatrics Regulations.
March 1, 2021

1st International Conference on Rare Diseases

1st International Conference on Rare Diseases Different infrastructures and organisational arrangements are required in each country to address the healthcare needs of its rare disease population […]
Become a member